News

CollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics

CollectiveMinds LLC, a leading executive search firm specializing in life sciences and healthcare, today announced the successful placement of Keith Meadors as Chief Commercial Officer of Genova Diagnostics, a pioneer in advanced diagnostic testing. The appointment marks another milestone for CollectiveMinds in connecting exceptional leadership talent with high-growth organizations across the diagnostics and life sciences sectors.

Meadors joins the company at a pivotal time as Genova continues to build on its momentum, expand its commercial capabilities, and strengthen its position in the diagnostic testing market. With more than 30 years of experience spanning clinical diagnostics, pharmaceuticals, and medical devices, he brings a distinguished track record of driving revenue growth, building high-performing commercial organizations, and aligning strategy with evolving healthcare demands.

Most recently, Meadors served as Vice President and General Manager at Labcorp, where he held full P&L accountability and overall leadership for the South Atlantic region. In that role, he led growth-focused strategies to deepen key customer partnerships, expand market share through innovative diagnostic offerings, and drive operational and organizational transformation to strengthen revenue performance, productivity, and customer experience.

Prior to Labcorp, Meadors held senior leadership roles at Precipio, Fresenius Kabi, Hospira (a Pfizer company), and Becton Dickinson. Throughout his career, he has consistently delivered results by aligning commercial strategy with evolving healthcare needs and fostering accountability across teams.

“From the outset, Keith demonstrated exactly the qualities that distinguish exceptional executive candidates — he arrived prepared, proactive, and deeply committed to the process. He consistently followed every engagement with detailed summary communications to both our team and the client, ensuring full alignment at every stage. Keith embodies what true executive readiness looks like, and we are proud to have placed a leader of his caliber with an organization as dynamic as Genova Diagnostics.”

— Tara Kochis, CEO, CollectiveMinds LLC

At Genova Diagnostics, Meadors will lead the company’s commercial organization, with responsibility for advancing growth strategy, strengthening customer relationships, and supporting the continued expansion of Genova’s market presence and diagnostic portfolio.

“Keith brings an exceptional combination of commercial leadership, operational discipline, and deep healthcare experience,” said Jeffrey Ledford, Chief Executive Officer of Genova Diagnostics. “As Genova continues to grow and evolve, we are excited to welcome a proven leader who understands how to build strong teams, create meaningful customer partnerships, and drive long-term value for the organization.”

The placement follows Genova’s acquisition of Cell Science Systems in January 2026, a strategic move that expanded the company’s position in the diagnostic testing market and broadened its opportunities for innovation and growth. Supported by ownership group Levine Leichtman Capital Partners, Genova continues to invest in the leadership and capabilities needed to execute on its next chapter.

“Genova Diagnostics has built a strong reputation for scientific rigor, innovation, and service,” said Meadors. “I’m honored to join the company at such an important time and look forward to working with the team to build on that foundation, expand our commercial impact, and help more customers access the value Genova brings to the market.”

Meadors holds a Master of Business Administration from Texas Christian University, is a Kellogg Scholar in Sales & Marketing through Northwestern University’s Kellogg School of Management, and earned a Bachelor of Science from North Carolina State University. He is also a certified medical technologist with the American Society for Clinical Pathology.

For more information about executive search services from CollectiveMinds LLC, visit collectivemindsllc.com. For information about Genova Diagnostics, visit gdx.net.

Read more here.

Recent News

07/23/2026

Activation Capital Expands the Bio+Tech Center, Doubling Laboratory Capacity to Strengthen Virginia’s Life Sciences Entrepreneurship and Innovation Ecosystem

Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, today announced an expansion of its Bio+Tech Center to support the continued growth of life sciences entrepreneurship across the region. Activation Capital’s Bio+Tech Center is a life sciences incubator located within the Virginia Bio+Technology Research Park. Serving as both a physical and programmatic

07/22/2026

Epidarex Announces Leadership Appointments

With the launch of our latest fund, Epidarex Capital IV, LP, we are pleased to announce several promotions. As we continue to grow and deepen our impact across the US and UK life science ecosystems, recognizing and elevating exceptional talent within our team is a vital part of that journey. These transitions reflect our continued

07/22/2026

Phlow Corp. Appoints Sripathy Venkatraman, Ph.D, As Chief Scientific Officer

Phlow Corp., a U.S.-based advanced pharmaceutical contract development and manufacturing organization (CDMO), dedicated to strengthening the nation’s pharmaceutical supply chain and protecting America’s medicine cabinet, today announced the appointment of Sripathy Venkatraman, Ph.D., MBA, as Chief Scientific Officer. Venkatraman brings more than 25 years of experience in pharmaceutical development, process chemistry, manufacturing, and scientific leadership. He